Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/04/2010 | CA2760541A1 Pyrido[4,3-b] indoles and methods of use |
11/04/2010 | CA2760530A1 Neuroprotective ganoderma compositions and methods of use |
11/04/2010 | CA2760527A1 Method of treatment of depression |
11/04/2010 | CA2760387A1 Thiophene derivative |
11/04/2010 | CA2760338A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis |
11/04/2010 | CA2760138A1 Neuroprotective compounds and their use |
11/04/2010 | CA2760133A1 Treatment of neurodegeneration and neuroinflammation |
11/04/2010 | CA2760048A1 Therapeutic agent for motor disorders |
11/04/2010 | CA2759984A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases |
11/04/2010 | CA2759859A1 Carbinol compound having heterocyclic linker |
11/04/2010 | CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof |
11/04/2010 | CA2759491A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
11/04/2010 | CA2759482A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
11/04/2010 | CA2759471A1 Heteroarylthiomethyl pyridine derivative |
11/04/2010 | CA2759230A1 Therapeutic agents 713 |
11/04/2010 | CA2758961A1 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors |
11/04/2010 | CA2758958A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors |
11/04/2010 | CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists |
11/04/2010 | CA2757757A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain |
11/04/2010 | CA2755780A1 Use of n2o gas for treating chronic pain |
11/04/2010 | CA2750678A1 Isoxazole derivatives |
11/03/2010 | EP2246427A1 Antibody capable of binding specifically to a -oligomer, and use thereof |
11/03/2010 | EP2246362A2 Polymer conjugates of mutated neublastin |
11/03/2010 | EP2246352A1 Novel diazabicyclic aryl derivatives and their medical use |
11/03/2010 | EP2246344A1 Pyrimidine compounds and medicinal composition thereof |
11/03/2010 | EP2246339A1 Derivatives of benzothiazepine and their use as modulators of AMPA and NMDA receptors |
11/03/2010 | EP2246338A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
11/03/2010 | EP2246334A1 Medicinal composition for inhibiting amyloid- protein deposition |
11/03/2010 | EP2246331A1 NR2B-selective NMDA-receptor antagonists |
11/03/2010 | EP2246065A1 Intrastriatal botulinum toxin therapy |
11/03/2010 | EP2246058A1 Noribogaine in the treatment of pain and drug addiction |
11/03/2010 | EP2246055A1 The use of aryl piperazine derivatives in manufacturing medicants for treating pain |
11/03/2010 | EP2246054A1 Fentanyl-containing patch for external use |
11/03/2010 | EP2246053A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
11/03/2010 | EP2246048A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis |
11/03/2010 | EP2245038A1 New macrolides and their use |
11/03/2010 | EP2245019A1 4, 5-dihydro-oxazol-2-yl amine derivatives |
11/03/2010 | EP2245016A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture |
11/03/2010 | EP2245011A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
11/03/2010 | EP2245006A1 Sulfonamides as orexin antagonists |
11/03/2010 | EP2244727A1 A method for restoring bmp-receptor signaling in a cell |
11/03/2010 | EP2244725A1 Novel peptides and protein and uses thereof |
11/03/2010 | EP2244718A2 Peptides having binding affinity to an antibody which recognizes an epitope on an 1 loop 2 or 2 loop 1 of an adrenoreceptor |
11/03/2010 | EP2244716A1 Fertilized egg isolate and use thereof |
11/03/2010 | EP2244707A1 Tetrahydrocyclopentaýc¨acridine derivatives as kinase inhibitors and biological applications thereof |
11/03/2010 | EP2244703A1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
11/03/2010 | EP2244702A1 Treatment of neural diseases or conditions |
11/03/2010 | EP2244701A2 Corroles for neuroprotection and neurorescue |
11/03/2010 | EP2244591A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
11/03/2010 | EP2125827B1 Azaspiro derivatives |
11/03/2010 | EP2121678B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
11/03/2010 | EP2121677B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
11/03/2010 | EP1976525B1 Piperidine and piperazine derivatives |
11/03/2010 | EP1951725B1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases |
11/03/2010 | EP1802313B1 Therapeutic agents trageting the ncca-atp channel and methods of use thereof |
11/03/2010 | EP1781291B1 Opioids for the treatment of the restlessness of the lower limbs |
11/03/2010 | EP1741792B1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
11/03/2010 | EP1703902B1 Memantine for the treatment of mild-to-moderate alzheimer's disease |
11/03/2010 | EP1646622B1 Tacrine derivatives as inhibitors of acetylcholinesterase |
11/03/2010 | EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring |
11/03/2010 | EP1496838B1 Substituted amides |
11/03/2010 | EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
11/03/2010 | EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug |
11/03/2010 | EP1296929B1 Modified forms of pharmacologically active agents and uses therefor |
11/03/2010 | EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection |
11/03/2010 | EP0568575B2 Test and model for alzheimer's disease |
11/03/2010 | CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide |
11/03/2010 | CN1951375B Nicotine transdermal formulation and its production method |
11/03/2010 | CN1950370B Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
11/03/2010 | CN1876004B A medicament for treating cerebrovascular disease |
11/03/2010 | CN1830457B Composition containing toad venom extraction used for pain relieving and anesthesia |
11/03/2010 | CN1805744B New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
11/03/2010 | CN101878301A Antibody and use thereof |
11/03/2010 | CN101878228A Human monoclonal nicotine specific antibodies |
11/03/2010 | CN101878219A Imidazolothiadiazoles for use as protein kinase inhibitors |
11/03/2010 | CN101878209A Oxypiperidine derivatives and methods of use thereof |
11/03/2010 | CN101878208A Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
11/03/2010 | CN101878204A Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
11/03/2010 | CN101878202A Gamma secretase modulators |
11/03/2010 | CN101878201A Fused indane compound |
11/03/2010 | CN101878200A Indoline compounds |
11/03/2010 | CN101878198A Phenylpyrrolidine compounds |
11/03/2010 | CN101878193A Bicyclic gamma-amino acid derivative |
11/03/2010 | CN101878027A Receptor targeting ligands |
11/03/2010 | CN101875961A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto |
11/03/2010 | CN101875931A siRNA recombinant slow virus for inhibiting human hephaestin gene expression and application |
11/03/2010 | CN101875691A Scorpion arialgesic antitumoral peptide mutant and preparation method thereof |
11/03/2010 | CN101874895A Application of CART (Cocaine Amphetamine Regulated Transcript) in preparing medicaments for treating alzheimers diseases |
11/03/2010 | CN101874893A Health-care medicinal liquor |
11/03/2010 | CN101874841A Total glycosides extractive of morinda plants, as well as preparation method and application thereof |
11/03/2010 | CN101874837A Product for quitting smoking and preparation method thereof |
11/03/2010 | CN101874817A Brucea javanica oil enteric-coated microcapsule, preparation method and application thereof |
11/03/2010 | CN101874811A Preparation method of silica modified nano pearl powder |
11/03/2010 | CN101874790A Orally disintegrating tablet of Rasagiline or medicine salts thereof and preparation method thereof |
11/03/2010 | CN101874783A Sustained-release preparation containing melatonin and preparation method thereof |
11/03/2010 | CN101874782A Sustained-release microballoons of dihydroetorphine or salt thereof and injection type prolonged action preparation thereof |
11/03/2010 | CN101874778A Alpha-asarone spraying agent and preparation method thereof |
11/03/2010 | CN101874630A Brain health-care product for improving memory and cognitive power |
11/03/2010 | CN101874533A Golden bamboo tea |
11/03/2010 | CN101318937B Alkaloid compounds, preparation method and application thereof |